Molecular Imaging and Biological Evaluation of HuMV833 Anti-VEGF Antibody: Implications for Trial Design of Antiangiogenic Antibodies (Q59617840)
Jump to navigation
Jump to search
scientific article published on 01 October 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Molecular Imaging and Biological Evaluation of HuMV833 Anti-VEGF Antibody: Implications for Trial Design of Antiangiogenic Antibodies |
scientific article published on 01 October 2002 |
Statements
Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implications for trial design of antiangiogenic antibodies (English)
Gordon C Jayson
Jamal Zweit
Clive Mulatero
Peter Julyan
Malcolm Ranson
Lynn Broughton
Leif Hakannson
Gerard Groenewegen
John Bailey
Nigel Smith
David Hastings
Jeremy Lawrance
Hamied Haroon
Tim Ward
Alan T McGown
Meina Tang
Dan Levitt
Sandrine Marreaud
Frederic F Lehmann
Manfred Herold
Heinz Zwierzina
European Organisation for Research and Treatment of Cancer Biological Therapeutic Development Group
1 October 2002